The Price is Right?
Rising drug prices are not helping the industry’s image problem
Charlotte Barker |
A recent survey revealed that over 70 percent of Americans believe that prescription drugs are too expensive, and of those, nearly 80 percent thought the pharma industry was mostly to blame (1). Perhaps that should come as no surprise in a month that saw an oncologist from one of America’s top cancer centers – Memorial Sloan-Kettering’s Leonard Saltz – use his talk at the American Society of Clinical Oncologists Annual Meeting to challenge the industry over the high price of new drugs.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.